MedPath

The effect of consuming the liposomal form of pistachio kernel oil on multiple sclerosis

Phase 3
Recruiting
Conditions
Multiple Sclerosis (MS).
Multiple sclerosis
Registration Number
IRCT20201219049765N1
Lead Sponsor
Rafsanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
500
Inclusion Criteria

Women aged 18 to 51 years
Definite diagnosis of multiple sclerosis with a descriptive measure of disability rate between 1 to 3

Exclusion Criteria

Taking corticosteroids during the study
Pregnancy and lactation
Active cardiovascular disease, liver disease, gastrointestinal disease, patients with Helicobacter pylori positive test, kidney disease, diabetes mellitus, respiratory disease and autoimmune diseases
Take multivitamin, mineral, antioxidant and pistachio kernel supplements during the 30 days before the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Concentration of inflammatory and anti-inflammatory factors. Timepoint: Intervention time (w0), 6 weeks after intervention (w6), 12 weeks after intervention (w12), 18 weeks after intervention (w18) and 24 weeks after intervention (w24). Method of measurement: With ELISA Kit.;Relative expression of genes of receptors of inflammatory and anti-inflammatory agents. Timepoint: Intervention time (w0), 24 weeks after intervention (w24). Method of measurement: By Realtime PCR.;The length and severity of the disease. Timepoint: Intervention time (w0), 6 weeks after intervention (w6), 12 weeks after intervention (w12), 18 weeks after intervention (w18) and 24 weeks after intervention (w24). Method of measurement: According to the descriptive measurement of disability rate.
Secondary Outcome Measures
NameTimeMethod
Allergies to pistachio compounds. Timepoint: Intervention time (w0), 6 weeks after intervention (w6), 12 weeks after intervention (w12), 18 weeks after intervention (w18) and 24 weeks after intervention (w24). Method of measurement: Qualitative examination with patient self-declaration.
© Copyright 2025. All Rights Reserved by MedPath